Stock Events

Stock Events

Zealand Pharma A/S. 

$9.31
141
+$0.83+9.79% Wednesday 13:35

Statistics

Day High
9.31
Day Low
9.31
52W High
16
52W Low
7.75
Volume
520
Avg. Volume
51
Mkt Cap
670.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.51
4.74
10.98
17.22
Expected EPS
-1.5059683464
Actual EPS
N/A

Financials

70.4%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.46BRevenue
1.02BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZLDPY. It's not an investment recommendation.
Novo Nordisk
47
NOVO-B.CO
NVIDIA
25
NVDA
Bavarian Nordic A/S
18
BAVA.CO
Vestas Wind Systems AS
17
VWS.CO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap201.05B
Novo Nordisk is a leading global healthcare company that competes with Zealand Pharma in the diabetes and obesity drug markets, areas where Zealand Pharma also operates.
Sanofi
SNY
Mkt Cap104.76B
Sanofi is a large pharmaceutical company that competes with Zealand Pharma in the development of treatments for diabetes and cardiovascular diseases.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly is a major player in the pharmaceutical industry, competing with Zealand Pharma in the diabetes care sector, particularly in the development of GLP-1 receptor agonists.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca competes with Zealand Pharma in several areas, including the development of new treatments for diabetes and other metabolic disorders.
Merck
MRK
Mkt Cap335.14B
Merck is a global healthcare company that competes with Zealand Pharma in the diabetes sector, particularly in the development of novel therapeutics.
Medicinova
MNOV
Mkt Cap64.48M
MediciNova is involved in the development of novel therapeutics for diseases with unmet medical needs, overlapping with Zealand Pharma's focus areas.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that has a broad range of products competing in the diabetes and cardiovascular markets, overlapping with Zealand Pharma's focus areas.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb operates in multiple therapeutic areas including cardiovascular diseases, directly competing with some of Zealand Pharma's therapeutic development areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes with Zealand Pharma in the development of treatments for cardiovascular diseases, among other areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals is involved in creating transformative medicines for people with serious diseases, competing with Zealand Pharma's innovative approach to drug development.

About

ZEALAND PHARMA A/S ORD
Show more...
CEO
Adam Sinding Steensberg
Employees
481
Country
Denmark
ISIN
US98920Y1064
WKN
000A3D4LL

Listings

OTC Link
US
ZLDPY
F
DE
22Z1.F
STU
DE
22Z.STU
CO
DK
ZEAL.CO

0 Comments

Share your thoughts

FAQ

What is Zealand Pharma A/S. stock price today?▼
The current price of ZLDPY is $9.31 USD — it has increased by +9.79% in the past 24 hours. Watch Zealand Pharma A/S. stock price performance more closely on the chart.
What is Zealand Pharma A/S. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Zealand Pharma A/S. stocks are traded under the ticker ZLDPY.
What is Zealand Pharma A/S. market cap?▼
Today Zealand Pharma A/S. has the market capitalization of 670.32M
When is the next Zealand Pharma A/S. earnings date?▼
Zealand Pharma A/S. is going to release the next earnings report on November 12, 2026.
What were Zealand Pharma A/S. earnings last quarter?▼
ZLDPY earnings for the last quarter are 8.43 USD per share, whereas the estimation was 0.14 USD resulting in a +5,791.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Zealand Pharma A/S. revenue for the last year?▼
Zealand Pharma A/S. revenue for the last year amounts to 1.46B USD.
What is Zealand Pharma A/S. net income for the last year?▼
ZLDPY net income for the last year is 1.02B USD.
How many employees does Zealand Pharma A/S. have?▼
As of August 18, 2026, the company has 481 employees.
In which sector is Zealand Pharma A/S. located?▼
Zealand Pharma A/S. operates in the Health & Wellness sector.
When did Zealand Pharma A/S. complete a stock split?▼
Zealand Pharma A/S. has not had any recent stock splits.
Where is Zealand Pharma A/S. headquartered?▼
Zealand Pharma A/S. is headquartered in Copenhagen, Denmark.